SEGMENT INFORMATION - Operating Income to Income Before Income Taxes Reconciliation (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Total	$ 187	$ 129
Intangible asset amortization expense	166	162
Operating income	187	129
Interest expense, net	78	117
Other income, net	(7)	(2)
Income from continuing operations before income taxes	116	14
Operating Segments
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Total	535	460
Operating income	535	460
Operating Segments | Medical Products and Therapies
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Total	227	197
Operating income	227	197
Operating Segments | Healthcare Systems and Technologies
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Total	67	112
Operating income	67	112
Operating Segments | Pharmaceuticals
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Total	78	87
Operating income	78	87
Operating Segments | Kidney Care
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Total	159	57
Operating income	159	57
Operating Segments | Other
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Total	4	7
Operating income	4	7
Segment Reconciling Items
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Unallocated corporate costs	(20)	(21)
Intangible asset amortization expense	(166)	(162)
Business optimization items	(57)	(134)
Acquisition and integration items	(5)	7
Separation-related costs	(92)	(9)
European Medical Devices Regulation	$ (8)	$ (12)